Italy's DiaSorin cautions on supply chain, logistics risks as it sets 2026 targets

DiaSorin SpA

20/03/2026 17:29

March 20 - Italian medical diagnostics group DiaSorin DIA.MI said on Friday it was targeting a 2026 profit margin in the range of 32%-33% while cautioning that the forecast excludes any potential indirect impact from the Middle East conflict.

DiaSorin also flagged the possibility of increased logistical and distribution challenges affecting the Asia-Pacific region, and of potential inflationary effects on its costs and supply chain.

Targets 2026 revenue growth in a range of 5%-6% at constant exchange rates

2025 EBITDA margin was 33%, in line with its revised target set in November

2025 adjusted EBITDA was 394 million euros

2025 revenue, net of its COVID-related business, rose 5% to 1.18 billion euros, meeting its 5% revised growth target set in November

Proposed dividend for the year of 1.30 euros per share

 (Reporting by Philippe Leroy Beaulieu in Gdansk; Editing by Matt Scuffham)

 ((philippe.leroybeaulieu@thomsonreuters.com))